CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 2,077,457
- Share change
- -85,412
- Total reported value
- $3,176,639
- Put/Call ratio
- 0.83%
- Price per share
- $1.53
- Number of holders
- 22
- Value change
- -$134,139
- Number of buys
- 6
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.6%
|
542,663
|
$912,000 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
374,251
|
$628,742 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.4%
|
357,615
|
$600,793 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
286,655
|
$481,580 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
188,164
|
$315,000 | — | 31 Mar 2024 | |
| Martin E. Cearnal |
3/4/5
|
Sr VP/Chief Commercial Officer, Director |
—
class O/S missing
|
163,473
|
$277,904 | — | 17 Mar 2022 | |
| Leo Pavliv |
3/4/5
|
SVP and Chief Development Off. |
—
class O/S missing
|
129,618
|
$220,351 | — | 31 May 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.73%
|
110,564
|
$185,748 | — | 31 Mar 2024 | |
| Joey A. Jacobs |
3/4/5
|
Director |
—
class O/S missing
|
98,415
|
$167,306 | — | 14 Jan 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
84,522
|
$142,019 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.5%
|
75,268
|
$126,450 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
33,700
|
$56,616 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
32,430
|
$54,482 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.15%
|
23,000
|
$38,640 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
16,338
|
$27,448 | — | 31 Mar 2024 | |
| Jonathan Griggs |
3/4/5
|
Director |
—
class O/S missing
|
14,803
|
$25,165 | — | 17 Mar 2021 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.08%
|
12,025
|
$20,202 | — | 31 Mar 2024 | |
| Michael Bonner |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
11,720
|
$19,924 | — | 17 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
11,274
|
$18,940 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.04%
|
5,747
|
$9,655 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
3,622
|
$6,085 | — | 31 Mar 2024 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$5,127 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,793
|
$3,012 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
100
|
$168 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
65
|
$109 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
20
|
$34 | — | 31 Mar 2024 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Mar 2024 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q2 2024
As of 30 Jun 2024,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,077,457 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, STATE STREET CORP, and Cresset Asset Management, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
22
Q2 2024 holders
22
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.